ACAD - ACADIA Pharmaceuticals Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$34.78
DETAILS
HIGH:
$40.00
LOW:
$29.00
MEDIAN:
$35.00
CONSENSUS:
$34.78
UPSIDE:
64.83%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 729,836 | $16.2M | 0.0% | -296,949 | DECREASED |
| Dalio | 141,812 | $3.2M | 0.0% | +3,633 | INCREASED |
| Greenblatt | 40,358 | $898,369 | 0.0% | +21,917 | INCREASED |
| Wood | 13,700 | $304,962 | 0.0% | -3,363,611 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-04 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | SELL | 1,332 | $21.79 | $29K |
| 2026-05-01 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | M-Exempt | 2,596 | -- | -- |
| 2026-05-04 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | SELL | 3,506 | $21.79 | $76K |
| 2026-05-01 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | M-Exempt | 6,815 | -- | -- |
| 2026-04-05 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | M-Exempt | 2,010 | -- | -- |
| 2026-04-05 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | M-Exempt | 5,276 | -- | -- |
| 2026-04-07 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | SELL | 2,709 | $22.20 | $60K |
| 2026-04-07 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | SELL | 1,030 | $22.20 | $23K |
| 2026-03-25 | Thompson Elizabeth H.Z. | officer: EVP, Head of Research & Dev | SELL | 3,435 | $21.47 | $74K |
| 2026-03-25 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | M-Exempt | 6,178 | -- | -- |
| 2026-03-24 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | M-Exempt | 8,138 | -- | -- |
| 2026-03-25 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | SELL | 4,177 | $21.47 | $90K |
| 2026-03-26 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | SELL | 37 | $21.72 | $803 |
| 2026-03-24 | Owen Adams Catherine | director, officer: Chief Executive Officer | M-Exempt | 23,509 | -- | -- |
| 2026-03-26 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | SELL | 1,097 | $21.65 | $24K |
| 2026-03-26 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | SELL | 12 | $21.73 | $260 |
| 2026-03-26 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | SELL | 3,171 | $21.65 | $69K |
| 2026-03-25 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | SELL | 833 | $21.47 | $18K |
| 2026-03-24 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | M-Exempt | 1,627 | -- | -- |
| 2026-03-25 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | M-Exempt | 2,142 | -- | -- |
| 2026-03-25 | Owen Adams Catherine | director, officer: Chief Executive Officer | SELL | 11,641 | $21.47 | $250K |
| 2026-03-24 | Thompson Elizabeth H.Z. | officer: EVP, Head of Research & Dev | M-Exempt | 6,715 | -- | -- |
| 2026-03-24 | Rhodes Jennifer J | officer: EVP, CHIEF LEGAL OFFICER, SEC | M-Exempt | 7,515 | -- | -- |
| 2026-03-25 | Rhodes Jennifer J | officer: EVP, CHIEF LEGAL OFFICER, SEC | SELL | 3,844 | $21.47 | $83K |
| 2026-03-03 | Poole Jonathan | director | A-Award | 3,565 | $22.50 | $80K |